Mironid appoints Dr Catherine Kelleher as Chief Medical Officer finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration Ventures September 13, 2023: Glasgow, Scotland.
Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Regulus Therapeutics Inc. (RGLS) saw an 8% increase in its shares on Wednesday after announcing the completion of patient enrollment in the second cohort of the Phase 1b Multiple-Ascending Dose (MAD) study of RGSL8429 for treating Autosomal Dominant Polycystic Kidney Disease (ADPKD).